Department of Psychiatry and Behavioral Sciences

The Einstein/Montefiore Psychology Internship Training Program is an APA-accredited, year-long predoctoral internship with an established reputation for providing exceptional training opportunities for future psychologists. 
Training Program Highlights:

  • APA-Accredited since June 21, 1985 and re-accredited until 2019
  • Three Training Specializations – Adult (4 intern positions each year), Child & Adolescent (2 intern positions each year), and Combined (2 intern positions each year)
  • Customizable Elective Rotations: Adolescent Depression and Suicide Program, Anxiety and Mood Program, Behavioral Health Integration Program, Transplant Surgery Program, Geropsychology, Children’s Hospital Behavioral Consultation Team, Substance Abuse Treatment Program, Behavioral Sleep Medicine Program, Neuropsychology Assessment Service, Supporting Healthy Relationships Program, HIV Clinic, Inpatient, Emergency Room, Addiction Psychiatry Consultation, Eating Disorders Program, the opportunity to participate in ongoing research…
  • Unparalleled training, supervision, and support by dedicated faculty with expertise in cognitive behavioral therapy, psychodynamic therapy, dialectical behavior therapy, acceptance and commitment therapy, mindfulness based cognitive therapy, family systems, interpersonal therapy, motivational interviewing…
  • Immersion into a vibrant, diverse urban patient population at one of the nation's top-ranked hospital psychiatry departments 
  • Exposure to and collaboration with expert physician scientists in virtually every field of medicine
  • Nearly a full day of didactic training, including four and a half hours of weekly seminars and Grand Rounds
  • A highly competitive benefits package

For more information, see the Psychology Internship Training Program website.

Upcoming Events

47th Annual Leadership Conference 

Date: May 31 - June 2, 2019
Brochure 2019 

 

Calendar

Thursday, January 30, 2020 | 12:00 PM
Pathways to Success at the Einstein Cores: " The Genomics Core"
Forchheimer Medical Science Building, 3rd Floor Lecture Hall

Sunday, February 09, 2020 | 8:00 AM
47th Annual Northeast Regional LMSA Conference
Robbins Auditorium,

view calendar

 

Media Spotlight

New Migraine Drug Shows Promise in Clinical Trial to Treat Patients With No Other Options

Richard Lipton, M.D., discusses the results of a Phase 3 clinical trial of Ubrogepant, a drug designed to treat acute migraine. Dr. Lipton is Edwin S. Lowe Professor and vice chair of the Saul R. Korey Department of Neurology at Einstein, and director of the Montefiore Headache Center.

(Friday, Dec 13, 2019)

coverage on other stories

 
Click here to log in